
Focal therapy is a growing minimally invasive treatment option for patients with low to intermediate risk prostate cancer that is completely contained (localized) within the prostate. The treatment targets and ablates (destroys) only specific parts of glands, organs, and tissue while preserving the surrounding and remaining tissue.
FLA of prostate tumors is an emerging targeted treatment technology that shows promise of low risk of side effects, such as erectile dysfunction and urinary incontinence.
An estimated 1.2 million patients are diagnosed with localized prostate cancer each year in the world.
For more information about the TRANBERG™ Thermal Therapy System, visit: .
For more information about custom 3D animations, visit .